Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AI innovation unlocks non-surgical way to detect brain cancer spread

2.

In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.

3.

If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version

4.

Month-Long Wait Times Caused by US Physician Shortage.

5.

O. A. J. Simpson passes away from cancer.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot